Home/Filings/4/0001955244-25-000013
4//SEC Filing

Berman David M 4

Accession 0001955244-25-000013

CIK 0001671927other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:10 PM ET

Size

14.9 KB

Accession

0001955244-25-000013

Insider Transaction Report

Form 4
Period: 2025-11-26
Berman David M
HEAD OF R&D
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2025-11-26$17.46/sh+69,404$1,211,79469,404 total
  • Sale

    Ordinary Shares

    2025-11-26$40.12/sh69,404$2,784,4880 total
  • Exercise/Conversion

    Ordinary Shares

    2025-11-28$17.46/sh+5,521$96,3975,521 total
  • Sale

    Ordinary Shares

    2025-11-28$40.09/sh5,521$221,3370 total
  • Exercise/Conversion

    Employee Share Option (Right to Buy)

    2025-11-2669,40449,266 total
    Exercise: $17.46Exp: 2028-09-12Ordinary Shares (69,404 underlying)
  • Exercise/Conversion

    Employee Share Option (Right to Buy)

    2025-11-285,52143,745 total
    Exercise: $17.46Exp: 2028-09-12Ordinary Shares (5,521 underlying)
Footnotes (4)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Immediately exercisable.

Issuer

Immunocore Holdings plc

CIK 0001671927

Entity typeother

Related Parties

1
  • filerCIK 0001955244

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:10 PM ET
Size
14.9 KB